Are BioCryst Pharmaceuticals (BCRX) Shares Offering Value After Recent Price Rebound [Yahoo! Finance]
BioCryst Pharmaceuticals, Inc. (BCRX)
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
biocryst.gcs-web.com/investor-relations
Company Research
Source: Yahoo! Finance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are looking at BioCryst Pharmaceuticals and wondering whether the current share price gives you good value, you are not alone. The stock closed at US$7.61, with returns of 9.5% over the past week and 12.1% over the past month, while the 1 year return sits at an 8.1% decline and the 5 year return at a 35.2% decline. Recent price moves have come against a backdrop of ongoing attention on BioCryst's pipeline and funding position, as investors weigh up the company's ability to support its programs and operations. Coverage has focused on how these factors could shape sentiment around the shares over time. On Simply Wall St's valuation checks, BioCryst Pharmaceuticals scores a 5 out of 6 , which suggests it screens as undervalued on most of the metrics assessed. Next we will walk through the key valuation approaches used here and then
Show less
Read more
Impact Snapshot
Event Time:
BCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BCRX alerts
High impacting BioCryst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
BCRX
News
- Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? [Yahoo! Finance]Yahoo! Finance
- BioCryst Pharmaceuticals Inc (BCRX) Q4 2025 Earnings Call Highlights: Record Profitability and ... [Yahoo! Finance]Yahoo! Finance
- BioCryst Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- BioCryst Reports Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
- BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.MarketBeat
BCRX
Earnings
- 2/26/26 - Beat
BCRX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/12/26 - Form SCHEDULE
- BCRX's page on the SEC website